160 related articles for article (PubMed ID: 29490009)
1. Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.
Ferrucci V; de Antonellis P; Pennino FP; Asadzadeh F; Virgilio A; Montanaro D; Galeone A; Boffa I; Pisano I; Scognamiglio I; Navas L; Diana D; Pedone E; Gargiulo S; Gramanzini M; Brunetti A; Danielson L; Carotenuto M; Liguori L; Verrico A; Quaglietta L; Errico ME; Del Monaco V; D'Argenio V; Tirone F; Mastronuzzi A; Donofrio V; Giangaspero F; Picard D; Remke M; Garzia L; Daniels C; Delattre O; Swartling FJ; Weiss WA; Salvatore F; Fattorusso R; Chesler L; Taylor MD; Cinalli G; Zollo M
Brain; 2018 May; 141(5):1300-1319. PubMed ID: 29490009
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines.
Bunt J; de Haas TG; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M
Mol Cancer Res; 2010 Oct; 8(10):1344-57. PubMed ID: 21047732
[TBL] [Abstract][Full Text] [Related]
3. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
[TBL] [Abstract][Full Text] [Related]
4. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CRX, a Group 3-specific oncogenic transcription factor, inhibits TGF-β/activin signaling in medulloblastoma cells.
Masurkar SA; Deogharkar A; Bharambe HS; Shirsat NV
Biochem Biophys Res Commun; 2021 Sep; 568():76-82. PubMed ID: 34192607
[TBL] [Abstract][Full Text] [Related]
7. The
Ampudia-Mesias E; Cameron CS; Yoo E; Kelly M; Anderson SM; Manning R; Abrahante Lloréns JE; Moertel CL; Yim H; Odde DJ; Saydam N; Saydam O
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674001
[TBL] [Abstract][Full Text] [Related]
8. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL
PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241
[TBL] [Abstract][Full Text] [Related]
9. Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development.
Aref D; Moffatt CJ; Agnihotri S; Ramaswamy V; Dubuc AM; Northcott PA; Taylor MD; Perry A; Olson JM; Eberhart CG; Croul SE
Brain Pathol; 2013 Mar; 23(2):178-91. PubMed ID: 22966790
[TBL] [Abstract][Full Text] [Related]
10. TGF-β Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma.
Santhana Kumar K; Neve A; Guerreiro Stucklin AS; Kuzan-Fischer CM; Rushing EJ; Taylor MD; Tripolitsioti D; Behrmann L; Kirschenbaum D; Grotzer MA; Baumgartner M
Cell Rep; 2018 Jun; 23(13):3798-3812.e8. PubMed ID: 29949765
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3'-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTEN.
Hartmann W; Digon-Söntgerath B; Koch A; Waha A; Endl E; Dani I; Denkhaus D; Goodyer CG; Sörensen N; Wiestler OD; Pietsch T
Clin Cancer Res; 2006 May; 12(10):3019-27. PubMed ID: 16707597
[TBL] [Abstract][Full Text] [Related]
12. PTEN loss mitigates the response of medulloblastoma to Hedgehog pathway inhibition.
Metcalfe C; Alicke B; Crow A; Lamoureux M; Dijkgraaf GJ; Peale F; Gould SE; de Sauvage FJ
Cancer Res; 2013 Dec; 73(23):7034-42. PubMed ID: 24154871
[TBL] [Abstract][Full Text] [Related]
13. ASC deficiency suppresses proliferation and prevents medulloblastoma incidence.
Knight ER; Patel EY; Flowers CA; Crowther AJ; Ting JP; Miller CR; Gershon TR; Deshmukh M
Oncogene; 2015 Jan; 34(3):394-402. PubMed ID: 24469054
[TBL] [Abstract][Full Text] [Related]
14. An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate.
Zagozewski J; Shahriary GM; Morrison LC; Saulnier O; Stromecki M; Fresnoza A; Palidwor G; Porter CJ; Forget A; Ayrault O; Hawkins C; Chan JA; Vladoiu MC; Sundaresan L; Arsenio J; Taylor MD; Ramaswamy V; Werbowetski-Ogilvie TE
Nat Commun; 2020 Jul; 11(1):3627. PubMed ID: 32686664
[TBL] [Abstract][Full Text] [Related]
15. Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice.
Jenkins NC; Rao G; Eberhart CG; Pedone CA; Dubuc AM; Fults DW
J Neurooncol; 2016 Feb; 126(3):415-24. PubMed ID: 26518543
[TBL] [Abstract][Full Text] [Related]
16. The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.
Qin N; Paisana E; Picard D; Leprivier G; Langini M; Custódia C; Cascão R; Conrad C; Peitzsch M; Stefanski A; Stühler K; Fischer U; Faria CC; Dietrich S; Reifenberger G; Remke M
J Neurooncol; 2023 Nov; 165(2):329-342. PubMed ID: 37976029
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma.
Stromecki M; Tatari N; Morrison LC; Kaur R; Zagozewski J; Palidwor G; Ramaswamy V; Skowron P; Wölfl M; Milde T; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE
Mol Oncol; 2018 Apr; 12(4):495-513. PubMed ID: 29377567
[TBL] [Abstract][Full Text] [Related]
18. OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells.
Bunt J; Hasselt NE; Zwijnenburg DA; Hamdi M; Koster J; Versteeg R; Kool M
Int J Cancer; 2012 Jul; 131(2):E21-32. PubMed ID: 21964830
[TBL] [Abstract][Full Text] [Related]
19. Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma.
Bunt J; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M
PLoS One; 2011; 6(10):e26058. PubMed ID: 22016811
[TBL] [Abstract][Full Text] [Related]
20. An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma.
Morabito M; Larcher M; Cavalli FM; Foray C; Forget A; Mirabal-Ortega L; Andrianteranagna M; Druillennec S; Garancher A; Masliah-Planchon J; Leboucher S; Debalkew A; Raso A; Delattre O; Puget S; Doz F; Taylor MD; Ayrault O; Bourdeaut F; Eychène A; Pouponnot C
EMBO Mol Med; 2019 Aug; 11(8):e9830. PubMed ID: 31328883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
